Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6235-6245
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6235
Figure 1
Figure 1 Glucose deprivation promotes drug resistance of colorectal cancer cells. A: GD decreased drug susceptibility to CRC cells. LoVo cells were treated with the indicated doses of the different drugs for 48 h under GD or normal culture condition. The in vitro drug sensitivity was tested by the CCK-8 assay; B: GD inhibited LOHP- and 5-FU-induced apoptosis. LoVo cells were treated with 0.1 μg/mL LOHP or 0.05 μg/mL 5-FU for 48 h. Hoechst 33258 nuclear staining and Annexin V/7-AAD staining assays were performed to detect apoptosis. C and D: GD promoted the expression of resistance gene MDR1. The mRNA and protein levels of MDR1 were examined by qRT-PCR and Western blot, respectively. aP < 0.05, bP < 0.01,cP < 0.001, control vs GD. GD: Glucose deprivation; CRC: Colorectal cancer.